Among the 19 potential TAA targets, 4 TAAs showed significantly higher autoantibody frequencies in the HCC group compared to the NHS group, which are DNMT3A, p16, HSP60, and HSPA5. The gene discussed is DNMT3A; the disease is hepatocellular carcinoma.